Data / Drug companies / Cardinal Health 414, LLC
Cardinal Health 414, LLC: 8 products in the FDA NDC directory, labeler code 65857
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Cardinal Health 414, LLC (labeler code 65857) lists 8 products in the FDA National Drug Code Directory, covering 6 finished drugs by generic name. By type: 7 prescription drugs, 1 bulk ingredients. Its main marketing category is generic drugs (ANDA). The newest product started marketing on April 18, 2024.
The request: Watch Cardinal Health 414, LLC (FDA labeler code 65857): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 65857
- Products in commercial distribution
- 8
- Packages
- 8
- Finished drugs by generic name
- 6
- Prescription products
- 7
- Over the counter products
- 0
- Flagged as original packager
- 7 of 7 products that carry the flag
- Started marketing in the last 12 months
- 0
- Earliest marketing start
- June 1, 2010
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 4 | 50% |
| New drug applications (NDA) | 3 | 37.5% |
| Bulk ingredients for compounding | 1 | 12.5% |
Products by type
| Type | Products | Share |
|---|---|---|
| Prescription drugs | 7 | 87.5% |
| Bulk ingredients | 1 | 12.5% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Tilmanocept | 2 | 1 |
| Fludeoxyglucose f-18 | 1 | 13 |
| Sodium fluoride f18 | 1 | 1 |
| Technetium tc 99m medronate | 1 | 2 |
| Kit for the preparation of technetium tc99m sestamibi | 1 | 1 |
| Ammonia n-13 | 1 | 13 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Injection | 3 | 37.5% |
| Kit | 2 | 25% |
| Injection, powder, lyophilized, for solution | 2 | 25% |
| Solution | 1 | 12.5% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
| Class | Products |
|---|---|
| Radioactive Diagnostic Agent | 5 |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Gallium chloride ga-68 | 65857-800 | Solution | Bulk ingredients for compounding | April 18, 2024 |
| Kit for the Preparation of Technetium Tc 99m Medronate | 65857-505 | Injection, powder, lyophilized, for solution | New drug applications (NDA) | December 1, 2020 |
| Fludeoxyglucose F-18 | 65857-150 | Injection | Generic drugs (ANDA) | January 2, 2019 |
| Kit for the preparation of Lymphoseek (technetium Tc 99m tilmanocept) | 65857-450 | Kit | New drug applications (NDA) | September 20, 2017 |
| Kit for the preparation of Lymphoseek (technetium Tc 99m tilmanocept) | 65857-425 | Kit | New drug applications (NDA) | September 20, 2017 |
| Sodium Fluoride F18 | 65857-300 | Injection | Generic drugs (ANDA) | July 30, 2015 |
| Ammonia N-13 | 65857-200 | Injection | Generic drugs (ANDA) | February 25, 2013 |
| Kit for the Preparation of Technetium Tc99m Sestamibi | 65857-500 | Injection, powder, lyophilized, for solution | Generic drugs (ANDA) | June 1, 2010 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.